Hepatitis C remains major problem for HIV patients despite antiretroviral therapy

The risk of hepatitis C-associated serious liver disease persists in HIV patients otherwise benefiting from antiretroviral therapy (ART) to treat HIV, a study has found. It has been suggested that ART slows hepatitis C-associated liver fibrosis; however, whether rates of severe liver complications in patients co-infected with HIV and hepatitis C receiving ART were similar to those with just hepatitis C remained unclear.